Main description:

This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed.
Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.

Contents:

1 Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases
Sanjay K. Murthy, Geoffrey C. Nguyen
2 Screening for Colon Cancer in Inflammatory Bowel DiseaseKendall Beck, Fernando Velayos
3 Skin Cancer Risk and Screening in Patients with Inflammatory Bowel DiseaseReid L Hopkins, Jamie Abbott, Debjani Sahni, Francis A. Farraye
4 Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease Kara De Felice, Sunanda Kane
5 Lymphoma Risk and Screening in Inflammatory Bowel DiseaseChip Alex Bowman, Garrett Lawlor
6 Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel DiseasesFreeha Khan, Bo Shen
7 Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel DiseaseFernanda Dal Bello, Alan C. Moss
8 Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases Helen Lee, Yecheskel Schneider, Gary R. Lichtenstein
9 Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical ApproachesSiddharth Singh
10 Cancer Risk and Screening in Pediatric Patients Matthew Kowalik, Stacy A. Kahn
11 Colorectal Cancer Risk and Screening in Geriatric Patients Elissa Lin, Seymour Katz
12 Use of Biologic Drugs Following an Initial Diagnosis of Malignancy Jordan Axelrad, Shannon Chang, David Hudesman